UK NEQAS Cardiac Markers
NHS Greater Glasgow & Clyde, operating UK NEQAS Cardiac Markers, is a UKAS accredited proficiency testing provider (No:8560)(BS EN ISO/IEC 17043:2010). We are a non-profit centre working within NHS Greater Glasgow and Clyde to improve cardiac biomarker investigations in the clinical laboratory sector for the benefit of patients.
Cardiac markers, especially Troponin I (cTnI) and Troponin T (cTnT), are critical measurements in acute coronary syndrome. Most authorities recommend that these measurements are carefully quality controlled. UKNEQAS Cardiac Marker schemes meet the external quality assessment (EQA) requirements of members by providing monthly distributions of samples with clinically relevant levels of these markers.
The scheme is a full member of UKNEQAS. The cardiac troponin EQA schemes have been in operation since 1998.
The following EQA schemes are all UKAS accredited:
Laboratory Based Schemes: cTnI (including high sensitivity methods), hsTnT, CKMB, Myoglobin, B-type Natriuretic Peptide (BNP) and NT-proB-type Natriuretic Peptide (NT-proBNP).
Point of Care Schemes - cTnI, cTnT, CKMB, Myoglobin, BNP and NT-proBNP.
The 4th Cardiac Marker Dialogues meeting took place in Glasgow on the 5th April 2019 with a record number of delegates. The 5th meeting is likely to be held in 2021. Information on the 2019 meeting is available on https://www.cmdmeeting.org.uk
UK NEQAS Cardiac Markers is operating normally. Distribution 266 for July 2020:
- Samples will be dispatched to laboratories during the week beginning 29th of June.
- Data entry for this distribution opens on the 6th July.
- Final date for return of results 24th of July.
We will continue to review our dispatch dates over the next couple of months and adapt if required.
As Abbott (calibrator product recall) and Siemens (method realignment) have or are making changes to their NT-proBNP methods I thought a short commentary on this analyte may be useful. This can be found at the end of your report for distribution 264. Alan Reid (Scheme Organizer)
HEART Editorial: High-sensitivity cardiac troponin and the early rule out of myocardial infarction: time for action
Editorial from Andrew Chapman and Nick Mills View Article
Troponins Touted as ‘Ally’ in COVID-19 Triage. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.047008